IPCALAB
IPCA Laboratories Limited
Pharmaceuticals
Share price
₹1,844
Market cap
₹46,801 Cr
1Y return
▲ 29%
A pharmaceutical manufacturer and marketer, Ipca Labs produces a wide range of medicines across therapeutic areas including antimalarials, anti-infectives, gastrointestinal treatments, and gynecological formulations. The company operates manufacturing facilities across India and exports its products to international markets. Its distinctive strength lies in its expertise in complex drug formulations, established distribution networks across Indian states, and a focus on affordable healthcare solutions for domestic and global markets.
Investors holding IPCA Laboratories Limited
9.51%
7.42%
4.12%
3.53%
2.04%
1.13%
1.07%
Recent moves 19
Moves19
Kotak OffshoreExited
Kotak Offshore has dropped off IPCA Laboratories Limited's latest shareholder list after previously holding a 1.14 percent stake. This shift indicates Kotak Offshore either completely exited its position or trimmed the holding below the 1 percent reporting threshold.
Read more
Axis Mutual FundIncreased
Axis Mutual Fund increased its stake in IPCA Laboratories Limited from 1.94% to 2.04%. The fund acquired 2,74,963 shares, raising its total holding to 51,86,894 shares.
Read more
HDFC Life InsuranceDecreased
HDFC Life Insurance trimmed its stake in IPCA Laboratories from 1.39% to 1.07%, selling 7,97,831 shares.
Read more
Nippon India Mutual FundDecreased
Nippon India Mutual Fund trimmed its stake in IPCA Laboratories from 2.79% to 2.72%, selling 1,77,430 shares.
Read more
Edelweiss Mutual FundIncreased
Edelweiss Mutual Fund raised its stake in IPCA Laboratories from 1.19% to 1.21%, purchasing 53,649 shares.
Read more
HDFC Mutual FundDecreased
HDFC Mutual Fund trimmed its stake in IPCA Laboratories from 9.54% to 9.51%, selling 77,694 shares.
Read more
SBI Life InsuranceDecreased
SBI Life Insurance trimmed its stake in IPCA Laboratories from 3.69% to 3.53%, selling 4,14,206 shares.
Read more
DSP Mutual FundDecreased
DSP Mutual Fund trimmed its stake in IPCA Laboratories from 4.64% to 4.12%, selling 13,25,763 shares.
Read more
HSBC Mutual FundIncreased
HSBC Mutual Fund increased its stake in IPCA Laboratories from 1.05% to 1.13%, buying 1,80,340 shares.
Read more
Kotak Mutual FundIncreased
Kotak Mutual Fund raised its stake in IPCA Laboratories from 6.36% to 7.42%, purchasing 26,75,309 shares.
Read more
Track the whales in IPCA Laboratories Limited
Get alerted the moment a top investor buys or sells.
Start 7 days for ₹1